S2Medical AB (publ) Signs Exclusive Distribution Agreement with Provas Medical Ltd for the Turkish Market
S2Medical AB (publ) ("S2Medical"), a leading developer of medical devices, is proud to announce that we have entered into an exclusive distribution agreement with Provas Medical Ltd ("Provas Medical") for the sale of products in the Epiprotect series on the Turkish market. This three-year agreement marks a significant milestone for S2Medical's expansion and presence in the Middle East and will strengthen the company's position as a pioneer in wound healing. The agreement entails commitments from Provas Medical to place orders worth approximately 4.7 million Swedish kronor, provided that